First Time Loading...

Nkarta Inc
NASDAQ:NKTX

Watchlist Manager
Nkarta Inc Logo
Nkarta Inc
NASDAQ:NKTX
Watchlist
Price: 6.82 USD -4.88% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

NKTX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. [ Read More ]

The intrinsic value of one NKTX stock under the Base Case scenario is 3.52 USD. Compared to the current market price of 6.82 USD, Nkarta Inc is Overvalued by 48%.

Key Points:
NKTX Intrinsic Value
Base Case
3.52 USD
Overvaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Nkarta Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NKTX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Nkarta Inc

Provide an overview of the primary business activities
of Nkarta Inc.

What unique competitive advantages
does Nkarta Inc hold over its rivals?

What risks and challenges
does Nkarta Inc face in the near future?

Has there been any significant insider trading activity
in Nkarta Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nkarta Inc.

Provide P/S
for Nkarta Inc.

Provide P/E
for Nkarta Inc.

Provide P/OCF
for Nkarta Inc.

Provide P/FCFE
for Nkarta Inc.

Provide P/B
for Nkarta Inc.

Provide EV/S
for Nkarta Inc.

Provide EV/GP
for Nkarta Inc.

Provide EV/EBITDA
for Nkarta Inc.

Provide EV/EBIT
for Nkarta Inc.

Provide EV/OCF
for Nkarta Inc.

Provide EV/FCFF
for Nkarta Inc.

Provide EV/IC
for Nkarta Inc.

Show me price targets
for Nkarta Inc made by professional analysts.

What are the Revenue projections
for Nkarta Inc?

How accurate were the past Revenue estimates
for Nkarta Inc?

What are the Net Income projections
for Nkarta Inc?

How accurate were the past Net Income estimates
for Nkarta Inc?

What are the EPS projections
for Nkarta Inc?

How accurate were the past EPS estimates
for Nkarta Inc?

What are the EBIT projections
for Nkarta Inc?

How accurate were the past EBIT estimates
for Nkarta Inc?

Compare the revenue forecasts
for Nkarta Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nkarta Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nkarta Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nkarta Inc compared to its peers.

Compare the P/E ratios
of Nkarta Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Nkarta Inc with its peers.

Analyze the financial leverage
of Nkarta Inc compared to its main competitors.

Show all profitability ratios
for Nkarta Inc.

Provide ROE
for Nkarta Inc.

Provide ROA
for Nkarta Inc.

Provide ROIC
for Nkarta Inc.

Provide ROCE
for Nkarta Inc.

Provide Gross Margin
for Nkarta Inc.

Provide Operating Margin
for Nkarta Inc.

Provide Net Margin
for Nkarta Inc.

Provide FCF Margin
for Nkarta Inc.

Show all solvency ratios
for Nkarta Inc.

Provide D/E Ratio
for Nkarta Inc.

Provide D/A Ratio
for Nkarta Inc.

Provide Interest Coverage Ratio
for Nkarta Inc.

Provide Altman Z-Score Ratio
for Nkarta Inc.

Provide Quick Ratio
for Nkarta Inc.

Provide Current Ratio
for Nkarta Inc.

Provide Cash Ratio
for Nkarta Inc.

What is the historical Revenue growth
over the last 5 years for Nkarta Inc?

What is the historical Net Income growth
over the last 5 years for Nkarta Inc?

What is the current Free Cash Flow
of Nkarta Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nkarta Inc.

Financials

Balance Sheet Decomposition
Nkarta Inc

Current Assets 253.1m
Cash & Short-Term Investments 248.2m
Other Current Assets 4.9m
Non-Current Assets 125.8m
PP&E 119.3m
Other Non-Current Assets 6.5m
Current Liabilities 23.3m
Accounts Payable 3.7m
Accrued Liabilities 18.8m
Other Current Liabilities 855k
Non-Current Liabilities 82.3m
Other Non-Current Liabilities 82.3m
Efficiency

Earnings Waterfall
Nkarta Inc

Revenue
0 USD
Operating Expenses
-131.7m USD
Operating Income
-131.7m USD
Other Expenses
14.1m USD
Net Income
-117.5m USD

Free Cash Flow Analysis
Nkarta Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NKTX Profitability Score
Profitability Due Diligence

Nkarta Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

Nkarta Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

NKTX Solvency Score
Solvency Due Diligence

Nkarta Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
60/100
Solvency
Score

Nkarta Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NKTX Price Targets Summary
Nkarta Inc

Wall Street analysts forecast NKTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NKTX is 19.64 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
122% Upside
Average
Price Target
19.64 USD
188% Upside
Highest
Price Target
26.25 USD
285% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NKTX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NKTX Price
Nkarta Inc

1M 1M
-31%
6M 6M
+239%
1Y 1Y
+44%
3Y 3Y
-80%
5Y 5Y
-86%
10Y 10Y
-86%
Annual Price Range
6.82
52w Low
1.31
52w High
15.71
Price Metrics
Average Annual Return -36.72%
Standard Deviation of Annual Returns 53.51%
Max Drawdown -98%
Shares Statistics
Market Capitalization 480.3m USD
Shares Outstanding 70 426 200
Percentage of Shares Shorted 8.69%

NKTX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Nkarta Inc Logo
Nkarta Inc

Country

United States of America

Industry

Biotechnology

Market Cap

480.3m USD

Dividend Yield

0%

Description

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California and currently employs 136 full-time employees. The company went IPO on 2020-07-10. Its modular NK cell engineering platform allows it to generate new product candidates. The Company’s engineered CAR-NK cells generally consist of an NK cell engineered with a targeting receptor, OX40 costimulatory domain, CD3z signaling moiety and a membrane-bound form of the cytokine IL15 (mbIL-15). The Company’s co-lead product candidates are NKX101 and NKX019. NKX101 is designed to innate NK biology to detect and kill cancerous cells. The primary activating receptor for NK cells is known as NKG2D, which works through the detection of stress ligands displayed by cancerous cells. The Company’s NK cell engineering platform is designed for engineering T cells and NK cells for understanding NK cell biology.

Contact

CALIFORNIA
South San Francisco
6000 Shoreline Court, Suite 102
+14155824923.0
https://www.nkartatx.com/

IPO

2020-07-10

Employees

136

Officers

CEO, President & Director
Mr. Paul J. Hastings
Chief Legal Officer & Corporate Secretary
Dr. Alicia J. Hager
Chief Financial & Business Officer and Principal Accounting Officer
Ms. Alyssa Levin C.A., CPA
Chief Technical Officer
Dr. Ralph Brandenberger Ph.D.
Chief Scientific Officer
Dr. James Trager Ph.D.
Vice President of Public Affairs and Investor Relations
Mr. Greg Mann
Show More
Chief Medical Officer
Dr. David R. Shook M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one NKTX stock?

The intrinsic value of one NKTX stock under the Base Case scenario is 3.52 USD.

Is NKTX stock undervalued or overvalued?

Compared to the current market price of 6.82 USD, Nkarta Inc is Overvalued by 48%.